Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Clinical trial NCT07335601 · RECRUITING

Trial details

NCT number: NCT07335601
Sponsor: Madrigal Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Start date: 2025-12-29
Primary completion: 2028-08-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.